Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2016 | 2 |
2017 | 3 |
2018 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer.
J Mol Endocrinol. 2017 Nov;59(4):R141-R154. doi: 10.1530/JME-17-0134. Epub 2017 Sep 20.
J Mol Endocrinol. 2017.
PMID: 28931558
Review.
IGF2 is a potential factor in RAI-refractory differentiated thyroid cancer.
Crezee T, Tesselaar MH, Jaeger M, Rabold K, Corver WE, Morreau H, Van Engen-Van Grunsven ACH, Smit JWA, Netea-Maier RT, Plantinga TS.
Crezee T, et al. Among authors: tesselaar mh.
Oncol Lett. 2021 Aug;22(2):590. doi: 10.3892/ol.2021.12851. Epub 2021 Jun 6.
Oncol Lett. 2021.
PMID: 34149901
Free PMC article.
Item in Clipboard
Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer.
Tesselaar MH, Crezee T, Schuurmans I, Gerrits D, Nagarajah J, Boerman OC, van Engen-van Grunsven I, Smit JWA, Netea-Maier RT, Plantinga TS.
Tesselaar MH, et al.
J Nucl Med. 2018 May;59(5):780-786. doi: 10.2967/jnumed.117.200675. Epub 2017 Dec 14.
J Nucl Med. 2018.
PMID: 29242405
Free article.
Item in Clipboard
Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non-medullary thyroid cancer.
Crezee T, Tesselaar MH, Nagarajah J, Corver WE, Morreau J, Pritchard C, Kimura S, Kuiper JG, van Engen-van Grunsven I, Smit JWA, Netea-Maier RT, Plantinga TS.
Crezee T, et al. Among authors: tesselaar mh.
Cell Oncol (Dordr). 2021 Jun;44(3):611-625. doi: 10.1007/s13402-021-00588-y. Epub 2021 Feb 3.
Cell Oncol (Dordr). 2021.
PMID: 33534128
Free PMC article.
Item in Clipboard
Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent Pathways.
Tesselaar MH, Crezee T, Swarts HG, Gerrits D, Boerman OC, Koenderink JB, Stunnenberg HG, Netea MG, Smit JW, Netea-Maier RT, Plantinga TS.
Tesselaar MH, et al.
Mol Cancer Ther. 2017 Jan;16(1):169-181. doi: 10.1158/1535-7163.MCT-16-0460. Epub 2016 Nov 11.
Mol Cancer Ther. 2017.
PMID: 27837029
Item in Clipboard
Novel single-chain antibody GD3A10 defines a chondroitin sulfate biomarker for ovarian cancer.
Vallen MJ, van Tilborg AA, Tesselaar MH, ten Dam GB, Bulten J, van Kuppevelt TH, Massuger LF.
Vallen MJ, et al. Among authors: tesselaar mh.
Biomark Med. 2014;8(5):699-711. doi: 10.2217/bmm.14.6.
Biomark Med. 2014.
PMID: 25123038
Item in Clipboard
Autophagy activity is associated with membranous sodium iodide symporter expression and clinical response to radioiodine therapy in non-medullary thyroid cancer.
Plantinga TS, Tesselaar MH, Morreau H, Corssmit EP, Willemsen BK, Kusters B, van Engen-van Grunsven AC, Smit JW, Netea-Maier RT.
Plantinga TS, et al. Among authors: tesselaar mh.
Autophagy. 2016 Jul 2;12(7):1195-205. doi: 10.1080/15548627.2016.1174802. Epub 2016 Apr 22.
Autophagy. 2016.
PMID: 27105307
Free PMC article.
Item in Clipboard
Cite
Cite